5 EASY FACTS ABOUT MRTX1133 STRUCTURE DESCRIBED

The identification of KRASG12C inhibitors has reignited fascination in targeting RAS proteins. This function describes the invention in the KRASG12D-specific inhibitor MRTX1133 and demonstrates the feasibility of potently and selectively focusing on this oncogenic variant.And clinical trials of combination therapy with KRAS G12C inhibitors and immu